News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Drug-resistant TB news

Show

From To
Drug-resistant TB
French authorities fear drug-resistant tuberculosis from Eastern Europe

For several months, French hospitals have been receiving increasing numbers of patients from Eastern Europe with a multi-drug-resistant tuberculosis (MDR TB).

Published
30 January 2013
From
Euronews
Drug-resistant TB
Hospital exposure the source of XDR-TB infections, underlining the need for adequate infection control

Numerous hospital transmissions – rather than a single source – fuelled the outbreak of extensively drug-resistant tuberculosis (XDR-TB) at Tugela Ferry, South Africa, in 2005-06, research published

Published
30 January 2013
By
Michael Carter
Drug-resistant TB
HIV and TB in Practice for nurses: Drug-resistant TB

This article summarises the key recommendations on the diagnosis and treatment of drug-resistant TB for nurses, and highlights examples of best practice in their care.

Published
28 January 2013
From
HIV & AIDS treatment in practice
Finance and funding
South Africa pays a high cost for drug resistant tuberculosis: study

According to a study a case of extensively drug resistant tuberculosis (TB) costs South Africa about $26 392 (R234 516.67) to treat, which is four times that of drug resistant TB, which costs $6 772, and a 103 times more than drug sensitive TB, which costs $257.

Published
21 January 2013
From
Times Live
Drug-resistant TB
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis

Several new classes of anti-tuberculosis agents are likely to become available in the coming decade. Ensuring prompt access to these drugs for patients without other treatment options is an important medical and public health issue. This article reviews the current state of ‘compassionate use’ and ‘expanded access’ programs for these new drugs, and identifies several shortcomings that will limit patient access to the drugs.

Published
11 January 2013
From
Interrnational Journal of Tuberculosis and Lung Disease
Drug-resistant TB
WHO to convene expert meeting on the use of bedaquiline for MDR-TB treatment

On 29-30 January the World Health Organization (WHO) will convene an expert group meeting on the use of bedaquiline for treatment of multidrug-resistant tuberculosis (MDR-TB).

Published
08 January 2013
From
Stop TB Partnership
TB treatment
US Food and Drug Administration approves Sirturo (bedaquiline) to treat MDR TB in adults

The US drug licensing authority has approved the first drug to be developed for multidrug-resistant tuberculosis (MDR TB). Bedaquiline is the first new TB and antimycobacterial drug of any kind to be approved since rifabutin in 1992, and the first new class of drugs for 45 years, since rifampicin in 1967.

Published
02 January 2013
From
FDA
Drug-resistant TB
Resistance to injectable second-line drugs in TB related to age, HIV status

CDC researchers have reported that several risk factors, including age and positive HIV status, were associated with acquired resistance to injectable second-line drugs in patients with drug-resistant tuberculosis.

Published
31 December 2012
From
Healio
Drug-resistant TB
Aggressive therapy for MDR-TB reduces risk of disease recurrence

Aggressive treatment of multidrug-resistant tuberculosis (MDR-TB) significantly reduces the risk of disease recurrence, investigators report in the online edition of Clinical Infectious Diseases. Patients who received

Published
31 December 2012
By
Michael Carter
Drug-resistant TB
New tuberculosis drug trial begins in South Africa

Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis, including patients with HIV co-infection.

Published
11 December 2012
From
Eurekalert Medicine & Health
← Prev12345...11Next →

Filter by country